Biotechnology and pharmaceutical sectors lead adoption, while recombinant trypsin production opens new growth opportunities worldwide.Austin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Trypsin Market Size & ...

Now, a new study by Duke University researchers reveals that when glucagon production is blocked, they can also “switch gears” to produce GLP-1 and even amp up its levels, enhancing insulin release ...

A daily pill previously shown to slow the progression of type 1 diabetes has now shown a loss of therapeutic benefit when stopped—affirming the promise of the treatment. In 2023, an Australian trial ...

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, ...

A nonprofit in Cambridge, Massachusetts is aiming to make insulin more accessible for diabetes patients in the United States by selling vials of the drug at a fraction of the cost. According to WBZ-TV ...

Federal Government has said it will begin production of insulin in Nigeria as part of efforts to reduce dependence on imported drugs and improve access to affordable diabetes treatment. Minister of ...

ANN ARBOR, Mich., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that Dr.

People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...

For the first time in history, a man with type 1 diabetes is producing his own insulin thanks to genetically engineered cells. #diabetes #typeonediabetes #insulin #crispr #geneticengineering ...

A new treatment for type 1 diabetes is moving closer to reality. In late 2024, a 46-year-old Swedish man received 17 injections of a unique pancreatic cell cocktail. The cells, donated from a healthy ...